Dear Colleagues, It is my great pleasure to announce the 2024 Asian Pharmacometrics Network (APN) Workshop and Symposium, which will be held virtually on 18-20 November.
Similar to previous years, this year's symposium will feature 14 invited speakers from various Asian countries, as well as 8 student speakers, which will encourage the participation of future pharmacometricians. In particular, an update from ICH-15 on the strategic role of pharmacometrics in accelerating MIDD will be presented in the keynote session, which will certainly enhance the core knowledge required in modern drug development for the audience. As usual, a pre-symposium workshop will be held on the day before the symposium, focusing on "Handling Pharmacometrics Case Study in the Optimisation of Drug Development and Clinical Therapy". The workshop and symposium are free of charge and can be registered at ugm.id/registerAPN<http://ugm.id/registerAPN>, and details of the program can be found at https://conference.farmasi.ugm.ac.id/. For further information, please contact the local host, Dr Akhmad Kharis Nugroho of Universitas Gadjah Mada, Indonesia, at <a.k.nugr...@ugm.ac.id<mailto:a.k.nugr...@ugm.ac.id>>. Best regards, APN Chair Kyungsoo Park --------------------------------------- Kyungsoo Park, PhD, MD Professor of Pharmacology Yonsei University College of Medicine 50-1 Yonsei-Ro, Seoul 03722, Korea Tel +82-2-2228-1735 / Fax +82-2-313-1894 Email ksp...@yuhs.ac<mailto:ksp...@yuhs.ac> 상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는 영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는 사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above message is intended solely for the named addressee and may contain trade secret, industrial technology or privileged and confidential information otherwise protected under applicable law including the Unfair Competition Prevention and Trade Secret protection act. Any unauthorized dissemination, distribution, copying or use of the information contained in this communication is strictly prohibited. If you have received this communication in error, please notify the sender by email and delete this communication immediately.
